Treatment
Medication clinical trials
We’re tracking 7,138 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06467097RecruitingPhase 3
Drug therapy vs. drug therapy plus radiation for limited kidney cancer
This trial tests whether adding radiation to standard drug therapy helps control kidney cancer that has spread to a few spots (oligometastatic). It is for people with clear cell renal cell carcinoma who have up to 5 metastases.
SeoulAges 20–80 - NCT06457776Recruiting
Jaw bone health in people taking bone-strengthening drugs
This study looks at how a specific jaw problem (osteonecrosis) may happen in people taking bone-strengthening medications. It aims to better understand and manage this side effect.
RomaAges 18 years+ - NCT03198546RecruitingPhase 1
CAR T therapy for advanced liver cancer with GPC3
This Phase 1 study tests a personalized immune-cell treatment (CAR T cells) for advanced liver cancer that has the GPC3 protein. It aims to see whether these engineered cells can find and kill cancer cells safely and help shrink the cancer.
Guangzhou, GuangdongAges 18–75 - NCT07829328Enrolling by invitationPhase 4
Can a special rinse help prevent early cavities between teeth?
This trial tests a special rinse called SAP P11-4 to see if it can stop or reverse early cavities between teeth before they need fillings. It may help keep your teeth healthy without more involved dental work.
Schofield Barracks, HawaiiAges 18–74 - NCT06461793RecruitingPhase 2
Higher dose radiation with hormone therapy for high-risk prostate cancer
This trial tests a higher dose of radiation given in fewer sessions (hypofractionated) combined with hormone therapy for men with high-risk prostate cancer that has not spread. A gel spacer called SpaceOAR is used to protect the rectum. The goal is to see if this approach is safe and effective.
SeoulAges 20 years+ - NCT07828106Recruiting
Remote diabetes monitoring for type 1 diabetes in children and youth
This study tests a remote diabetes monitoring system that uses WhatsApp to help improve blood sugar control and quality of life in children and young people with type 1 diabetes. It is for those already using a Dexcom CGM and a closed-loop insulin pump.
Ramat GanAges 1–25 - NCT07826533Recruiting
Intravenous papaverine for term prelabour rupture of membranes
This study tests whether giving papaverine through a vein can help start labour in women whose water has broken but who are not yet having contractions. Papaverine is a medicine that relaxes smooth muscles, which may help the cervix prepare for delivery.
HolonAges Any age - NCT06461819RecruitingPhase 2
Higher radiation dose for low-to-intermediate prostate cancer
This trial tests if giving a higher dose of radiation in fewer sessions, while using SpaceOAR to protect the rectum, is safe for men with low-to-intermediate risk prostate cancer that hasn't spread.
SeoulAges 20 years+ - NCT07831824RecruitingPhase 2/Phase 3
Imaging drug to find prostate cancer spread before or after treatment
This trial tests an imaging agent that helps find cancer that has spread beyond the prostate, either when first diagnosed or if it comes back after treatment. The goal is to see what dose works best for clear pictures.
Grand Rapids, MichiganAges 18 years+ - NCT06461377RecruitingPhase 4
GLP-1RA for heart nerve damage in type 2 diabetes
This trial tests whether a type of diabetes medicine called GLP-1RA can help prevent or improve nerve damage in the heart caused by diabetes. It is for people with type 2 diabetes who are overweight or obese.
Nanjing, JiangsuAges 18–70 - NCT06161207RecruitingPhase 3
Laparoscopic surgery for stomach cancer using 3D and dye
This trial tests a new way to remove stomach cancer using 3D-4K cameras and a special dye during laparoscopic (keyhole) surgery. It may help surgeons see the cancer better and remove it more precisely.
Fuzhou, FujianAges 18–75 - NCT03769129Recruiting
Pembrolizumab plus lung ablation for advanced lung cancer
This trial tests whether combining pembrolizumab (an immune treatment) with a lung ablation procedure can be safer and more effective for advanced non-small cell lung cancer after standard first treatment fails or the cancer comes back. It may help shrink tumors and improve control of the disease.
Guangzhou, GuangdongAges 18 years+ - NCT06302803Recruiting
Modified intermittent eating for weight loss trial
This trial tests a modified intermittent eating plan to help people with obesity lose weight and keep it off. It compares different eating schedules to see which works best for long-term weight control.
Guangzhou, GuangdongAges 18–75 - NCT07833930Recruiting
Breakthrough pain after arm numbing block in diabetic patients
This study looks at whether people with diabetes have more breakthrough pain (pain that breaks through despite the block) within 48 hours after an arm surgery with a specific type of nerve block. The goal is to understand and improve pain management for diabetic patients.
TaiyuanAges 18–80 - NCT07830602Recruiting
Home breathing and exercise program for interstitial lung disease
This study tests a home-based program of breathing exercises and physical activity for people with interstitial lung disease, aiming to improve breathlessness and daily function.
Chandigarh, ChandigarhAges 18–75 - NCT07831993RecruitingPhase 2
Immunotherapy with chemotherapy for advanced bile duct cancer
This trial tests a new combination of a drug that helps your immune system fight cancer, called sintilimab, along with chemotherapy. It is for people who have bile duct cancer or gallbladder cancer that has spread to other parts of the body and have not had treatment for this stage yet. The goal is to see if this combination helps shrink tumors or stops them from growing.
Nanjing, JiangsuAges 18–75 - NCT07829705RecruitingPhase 2
Amyloid PET scan to measure treatment response in AL cardiac amyloidosis
This study uses an amyloid PET/CT scan to see how well first-line treatment is working in people with AL cardiac amyloidosis, a condition where abnormal proteins build up in the heart. The scan may help doctors better understand and monitor the disease.
BeijingAges 18 years+ - NCT07832318Recruiting
Herbal injection for chronic sciatica
This trial tests whether an herbal injection into acupuncture points can safely reduce leg pain from sciatica that has lasted more than 3 months. It compares this treatment to usual care, and may offer a new option for people who haven't found relief.
Bucheon-si, Gyeonggi-doAges 19–70 - NCT07827196Recruiting
Brain stimulation for behavior changes in early Alzheimer's
This study tests whether a gentle, non-invasive brain stimulation technique called transcranial random noise stimulation (tRNS) can help reduce troubling behavioral and psychological symptoms (like agitation or anxiety) in people with early Alzheimer's disease. Participants continue their usual medication and receive either real or fake stimulation to see if it improves symptoms.
Hefei, AnhuiAges 45–84 - NCT07829601Recruiting
Doctors' prevention habits study
This study looks at how doctors and medical residents prevent disease. If you are a doctor or medical resident, you can join and share your habits to help improve healthcare.
Clermont-FerrandAges Any age - NCT07832578RecruitingEarly Phase 1
Aspirin with or without rivaroxaban for severe leg artery disease
This trial compares two ways to prevent blood clots in people with severe leg blockage (chronic limb-threatening ischemia) who are not having surgery. It tests aspirin alone versus a newer blood thinner (rivaroxaban) plus aspirin, to see which works better in preventing complications.
Lahore, Punjab ProvinceAges 40–70 - NCT07830472Recruiting
Robot leg training for age-related muscle loss
This study tests whether a leg-training robot can help older adults with sarcopenia—a condition of losing muscle mass and strength as they age—improve their leg strength and function. The robot supports your legs during exercises, which might be safer and more effective than doing them alone.
Taipei, Taipei CityAges 60 years+ - NCT04842812RecruitingPhase 1
Personalized immune cell therapy for advanced solid tumors
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
GuangzhouAges 18–85 - NCT03778814RecruitingPhase 1
Personalized T-cell therapy for advanced lung or solid tumors
This Phase 1 study tests a lab-made immune cell treatment made from your own blood cells (T cells) to fight advanced lung cancer or other solid tumors. You may be eligible if your tumor can be biopsied and the lab can successfully prepare T cells that strongly recognize and attack your cancer.
Guanzhou, GuangdongAges 18–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,138 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.